News

Jon Alberdi joins the Roving Reporter series to discuss pricing, reimbursement and access challenges in cell and gene therapy

VIVEbiotech’s CEO takes part in a new Roving Reporter episode discussing how recent clinical, regulatory, and commercial milestones are shaping the next stage of cell and gene therapy.

Natalia Elizalde shares her perspective on emerging approaches that could shape the next generation of cell and gene therapies

Commercial readiness is becoming an increasingly important consideration from the earliest stages of advanced therapy development.

The company marks its third day by advancing strategic connections and showcasing its lentiviral vector capabilities

The company will join the Spain Pavilion by ICEX at one of the leading global events in the biotechnology sector

VIVEbiotech’s Chief Business Development Officer is featured in The Medicine Maker’s Roving Reporter series, recorded at Advanced Therapies London 2026

The company continues its activity at the congress, fostering scientific exchange and networking with the global gene and cell therapy community

The company strengthens its position in gene and cell therapy with lentiviral manufacturing insights

A successful event strengthening connections in the cell & gene therapy community

Connecting with partners and showcasing innovation in lentiviral vector manufacturing

Meet VIVEbiotech at ISCT 2026 and discover how we are advancing lentiviral vector manufacturing from early development to commercial scale.

The company participated simultaneously in the Cell & Gene Meeting on the Med in Rome and BIO KOREA in Seoul, engaging in global CGT discussions across two continents.

Starting April 28, the company will participate simultaneously in two major international industry events across Europe and Asia.

Insights from an IBTV interview at Advanced Therapies London 2026

The company strengthens its global presence at the Cell & Gene Meeting on the Med and BIO KOREA

Building on its established footprint in the region, the company reinforces participation in key biotech events across one of the world’s most dynamic cell and gene therapy ecosystems.

Lentiviral vector innovation, collaboration, and new opportunities in cell and gene therapy at ExCeL London.

Our team is already on site at ExCeL London as we join a new edition of the Advanced Therapies Congress, organized by Terrapinn.

VIVEbiotech will be at ExCeL London for an important event in its international growth agenda.

A week of innovation, collaboration, and valuable exchanges in San Diego.

The team arrives at the San Diego Convention Center ready for a week of innovation, collaboration, and global engagement.

The company will attend as a Bronze Sponsor and present its capabilities in lentiviral vector development and manufacturing.

Over 25 students from Aldapeta María Ikastetxea visited our facilities to learn more about the biotech industry.

A decade of innovation, collaboration, and dedication marked in a special festive celebration.

Our colleague Idoia Mármol shared her professional experience with more than 200 students, encouraging young women to pursue careers in STEM fields.

The event, organized by Kutxa Fundazioa at the Kursaal, brought together students with professionals from various sectors to inspire their academic and professional futures.

A day dedicated to connecting with talent and sharing our mission in biotechnology.

Connecting with global experts and sharing our know-how in lentiviral vector manufacturing.

The forum, organised by El Diario Vasco and KPMG, has featured leading experts who analysed the role of strategic sectors such as biotechnology, energy and Industry 4.0 in the future of the region.

The event, organised in conjunction with the SETGyC, will be held from 7 to 10 October in Seville.

Our team is attending Advanced Therapies Europe at Hotel Arts Barcelona to share knowledge and connect with professionals in the advanced therapies sector.

Visit us at booth no. 26 from September 2–4 and discover our lentiviral vector services for advanced therapies.

Our Chairperson and CEO will represent VIVEbiotech at one of the world’s most important biotech gatherings.

VIVEbiotech showcases its expertise in lentiviral vectors for in-vivo administration at ASGCT 2025, with a talk by Natalia Elizalde and ongoing meetings at booth 1927 in New Orleans.

Chairperson Dr. Stefan Beyer to represent VIVEbiotech at a key gathering of biotech professionals in Basel.

Technological Innovation researcher Ane Arrasate showcases lentiviral vector manufacturing advancements.

Meet Natalia Elizalde, our dedicated representative, and explore how we can support your advanced therapies programs.

Meet Our Experts at Advanced Therapies and Bioprocessing Summit Europe.

Evolving Landscape of Cell and Gene Therapy (CGT) Manufacturing: Key Takeaways from Natalia Elizalde.

This week, VIVEbiotech proudly participates in the Advanced Therapies Week hosted by Phacilitate at the Kay Bailey Hutchison Convention Center, Dallas.

VIVEbiotech will be an exhibitor at Phacilitate’s Advanced Therapies Week to be held in Dallas from January 20-23.

The European Society of Gene and Cell Therapy´s annual congress is in full swing.

VIVEbiotech is participating as a Silver Sponsor in Innovative Therapies Days, a 2-day conference that takes place every year in Besançon, in the Région Bourgogne-Franche-Comté in France.

As in several past editions, VIVEbiotech is participating in Cell & Gene Meeting on the Mesa.

Natalia Elizalde, Chief Business Development Officer of VIVEbiotech, is participating in Phacilitate’s Advanced Therapies Europe conference.

Natalia Elizalde, Chief Business Development Officer of VIVEbiotech, was interviewed by IBTV during the ASGCT´s annual meeting that took place three weeks ago in Baltimore.

Juan Camilo Estrada, Head of Analytical Development at VIVEbiotech, will be presenting at the upcoming SLAS Europe 2024 Conference & Exhibition.

VIVEbiotech is participating at the American Society of Gene & Cell Therapy´s (ASGCT) Annual Meeting at the Baltimore Convention Center.

VIVEbiotech participates in Cell & Gene Meeting on the Mediterranean that is taking place these days in the beautiful city of Rome.

VIVEbiotech is participating in the 19th edition the Advanced Therapies Congress that has just started and will take place today and tomorrow at the ExCel in London.

VIVEbiotech has successfully participated in the Advanced Therapies Week conference in Miami.

Today VIVEbiotech has participated in the Industria Eguna organised by ADEGI – Business Association of Gipuzkoa.

VIVEbiotech participated yesterday in the fifth edition of New Culturers Gunea that took place in Fabrika NCE.

VIVEbiotech has been invited to participate in the Talent Spot of the Basque Open Industry, held at the Bilbao Exhibition Centre (BEC) in Barakaldo and supported by the SPRI Group.

VIVEbiotech will participate in the Feria de Empleo PICE 2023 that will take place at the headquarters of the Chamber of Gipuzkoa, next Tuesday, October 31 from 9:30 am.

VIVEbiotech is participating in the ESGCT (European Society of Gene and Cell Therapy) Annual Congress taking place in Brussels this week.

VIVEbiotech is participating in Innovative Therapies Days, “an oasis of innovation 2.5 hours from Paris”!

VIVEbiotech is participating once again in the Cell & Gene Meeting on the Mesa congress in California.

Biospain is a biotechnology congress organized by AseBio – Asociación Española de Empresas Biotecnológicas and is held every two years in a different city in Spain.

Soledad Baños-Mateos, senior researcher of the Department of Technological Innovation of VIVEbiotech, has participated in the XVI Congreso Anual de Biotecnología (BAC Badajoz 2023) that has been held in Badajoz from 12 to 14 July.

Gurutz Linazasoro, CEO of VIVEbiotech, will participate tomorrow in a round table discussion entitled “Boosting science and research of high quality and impact” at the Bioscience Forum organised by Noticias de Gipuzkoa.

VIVEbiotech has successfully participated in 5 international congresses in the first half of the year.

Bárbara Rodríguez-Urretavizcaya, Analytical Development Scientist, has presented at two Gyrolab Technology Seminars.

Gurutz Linazasoro, CEO of VIVEbiotech and coordinator of the AseBio´s, the Spanish Bioindustry Association ´s, advanced therapies working group, participated yesterday in a round table at Transfiere, the European Forum for Science, Technology and Innovation.